-
Kenya's economy faces climate change risks: World Bank
-
Ex-prince Andrew again caught up in Epstein scandal
-
How Lego got swept up in US-Mexico trade frictions
-
Snow storm barrels into southern US as blast of icy weather widens
-
Ex-prince Andrew dogged again by Epstein scandal
-
'Malfunction' cuts power in Ukraine. Here's what we know
-
Women in ties return as feminism faces pushback
-
Ship ahoy! Prague's homeless find safe haven on river boat
-
Epstein offered ex-prince Andrew meeting with Russian woman: files
-
China factory activity loses steam in January
-
Melania Trump's atypical, divisive doc opens in theatres
-
Gold, silver prices tumble as investors soothed by Trump Fed pick
-
US Senate votes on funding deal - but shutdown still imminent
-
Trump expects Iran to seek deal to avoid US strikes
-
NASA delays Moon mission over frigid weather
-
Fela Kuti: first African to get Grammys Lifetime Achievement Award
-
Cubans queue for fuel as Trump issues oil ultimatum
-
France rescues over 6,000 UK-bound Channel migrants in 2025
-
Analysts say Kevin Warsh a safe choice for US Fed chair
-
Fela Kuti to be first African to get Grammys Lifetime Achievement Award
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Social media fuels surge in UK men seeking testosterone jabs
-
Trump nominates former US Fed official as next central bank chief
-
Chad, France eye economic cooperation as they reset strained ties
-
Artist chains up thrashing robot dog to expose AI fears
-
Dutch watchdog launches Roblox probe over 'risks to children'
-
Cuddly Olympics mascot facing life or death struggle in the wild
-
UK schoolgirl game character Amelia co-opted by far-right
-
Panama court annuls Hong Kong firm's canal port concession
-
Asian stocks hit by fresh tech fears as gold retreats from peak
-
Apple earnings soar as China iPhone sales surge
-
With Trump administration watching, Canada oil hub faces separatist bid
-
What are the key challenges awaiting the new US Fed chair?
-
Moscow records heaviest snowfall in over 200 years
-
Polar bears bulk up despite melting Norwegian Arctic: study
-
Waymo gears up to launch robotaxis in London this year
-
French IT group Capgemini under fire over ICE links
-
Czechs wind up black coal mining in green energy switch
-
EU eyes migration clampdown with push on deportations, visas
-
Northern Mozambique: massive gas potential in an insurgency zone
-
Gold demand hits record high on Trump policy doubts: industry
-
UK drugs giant AstraZeneca announces $15 bn investment in China
-
Ghana moves to rewrite mining laws for bigger share of gold revenues
-
Russia's sanctioned oil firm Lukoil to sell foreign assets to Carlyle
-
Gold soars towards $5,600 as Trump rattles sabre over Iran
-
Deutsche Bank logs record profits, as new probe casts shadow
-
Vietnam and EU upgrade ties as EU chief visits Hanoi
-
Hongkongers snap up silver as gold becomes 'too expensive'
-
Gold soars past $5,500 as Trump sabre rattles over Iran
-
Samsung logs best-ever profit on AI chip demand
Johnson & Johnson faces UK lawsuit over talc cancer claim
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging people diagnosed with cancers were exposed to asbestos in its talcum powder, lawyers said Thursday.
The company has faced a series of similar lawsuits in North America, with the latest UK claim filed in the High Court in London.
The law firm representing around 3,000 complainants in Britain said the compensation claim "is estimated to be more than £1 billion" ($1.3 billion).
They allege that either they or a family member developed forms of ovarian cancer or mesothelioma from using J&J's Baby Powder.
"The claim, which covers the period from 1965 to 2023, details how Johnson & Johnson knew that their talc products contained carcinogenic fibres, including asbestos, for more than 50 years," KP Law said.
The company "chose to keep it on the market in the pursuit of profit," it added, claiming J&J only withdrew their mineral talc from Britain in 2023, three years after it was taken off North American shelves.
A Johnson & Johnson spokesperson referred enquiries to its former consumer health arm Kenvue, which it separated from in August 2023.
"As a part of that separation, Kenvue retained the responsibility and any purported liability for talc related litigation outside of the United States and Canada," the spokesperson said.
A Kenvue spokesperson said the safety of J&J's Baby Powder "is backed by years of testing by independent and leading laboratories, universities, and health authorities in the UK and around the world".
The spokesperson added "the high-quality cosmetic grade talc" used in the powder "was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer".
US courts in April rejected a J&J offer to pay approximately $8 billion over 25 years to settle around 90,000 civil complaints there related to ovarian issues, without admitting liability.
The World Health Organization's cancer agency classified talc as "probably carcinogenic" for humans in July last year.
A summary of studies published in 2020 covering 250,000 women in the United States did not find a statistical link between the use of talc on the genitals and the risk of ovarian cancer.
M.P.Jacobs--CPN